当前期刊: Journal of Dual Diagnosis Go to current issue    加入关注   
显示样式:        排序: IF: - GO 导出
我的关注
我的收藏
您暂时未登录!
登录
  • Motives for Smoking in Those With PTSD, Depression, and No Psychiatric Disorder.
    J. Dual Diagn. (IF 1.338) Pub Date : 2020-05-12
    Marika S Rosenblum,Jessica L Engle,Megan E Piper,Jesse T Kaye,Jessica W Cook

    Objective: Approaches for effectively treating smoking in those with posttraumatic stress disorder (PTSD) and with major depressive disorder (MDD) could be improved by identifying motivational processes underlying their tobacco dependence. The goal of this study was to identify the motivational processes influencing smoking dependence among smokers with PTSD and with MDD relative to non-diagnosed controls

    更新日期:2020-05-12
  • Interaction of Cannabis Use and Aging: From Molecule to Mind.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-09-30
    Hye Bin Yoo,Jennifer DiMuzio,Francesca M Filbey

    Given the aging Baby Boomer generation, changes in cannabis legislation, and the growing acknowledgment of cannabis for its therapeutic potential, it is predicted that cannabis use in the older population will escalate. It is, therefore, important to determine the interaction between the effects of cannabis and aging. The aim of this report is to describe the link between cannabis use and the aging

    更新日期:2020-04-23
  • The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-09-03
    C Hindocha,J Cousijn,M Rall,M A P Bloomfield

    Objectives: Posttraumatic stress disorder (PTSD) is a potentially debilitating mental health problem. There has been a recent surge of interest regarding the use of cannabinoids in the treatment of PTSD. We therefore sought to systematically review and assess the quality of the clinical evidence of the effectiveness of cannabinoids for the treatment of PTSD. Method: We included all studies published

    更新日期:2020-04-23
  • Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-10-09
    Amber L Milligan,Thomas A Szabo-Pardi,Michael D Burton

    Understanding how the body regulates pain is fundamental to develop rational strategies to combat the growing prevalence of chronic pain states, opioid dependency, and the increased financial burden to the medical care system. Pain is the most prominent reason why Americans seek medical attention and extensive literature has identified the importance of the endocannabinoid pathway in controlling pain

    更新日期:2020-04-23
  • Cannabis Use in Adolescence: A Review of Neuroimaging Findings.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-07-16
    Yann Chye,Erynn Christensen,Murat Yücel

    Objective: Shifting policies and widespread acceptance of cannabis for medical and/or recreational purposes have fueled worries of increased cannabis initiation and use in adolescents. In particular, the adolescent period is thought to be associated with an increased susceptibility to the potential harms of repeated cannabis use, due to being a critical period for neuromaturational events in the brain

    更新日期:2020-04-23
  • Cannabis and Epilepsy.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-08-06
    Alexander Doyle,Jay Harvey

    Objective: In recent years, the use of cannabidiol in the treatment of refractory epilepsy has been increasingly investigated and has been gaining public support as a novel way to treat these disorders. Marijuana has been used for medical purposes for thousands of years, and a lot of research has been conducted over the last several decades into the chemistry and pharmacology of marijuana and its many

    更新日期:2020-04-23
  • Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-09-13
    Hollis C Karoly,J Megan Ross,Jarrod M Ellingson,Sarah W Feldstein Ewing

    Objective: Amidst the evolving policy surrounding cannabis legalization in the United States, cannabis use is becoming increasingly prevalent as perceptions of harm decrease, particularly among adolescents. Cannabis and alcohol are commonly used by adolescents and are often used together. However, developmental research has historically taken a "single substance" approach to examine the association

    更新日期:2020-04-23
  • Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-06-22
    Jacqueline C Duperrouzel,Karen Granja,Ileana Pacheco-Colón,Raul Gonzalez

    Objective: As the perceived risk of cannabis use continues to decline among youths and access continues to increase, it has become more important to synthesize the rapidly growing literature on the effects of cannabis on neurocognition. Hundreds of studies examining associations between cannabis use and neurocognitive functioning have been published in recent decades. However, results often differ

    更新日期:2020-04-23
  • Cannabis Use and the Risk for Psychosis and Affective Disorders.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-10-24
    Lucia Sideli,Harriet Quigley,Caterina La Cascia,Robin M Murray

    Objective: This review discusses the relationship between cannabis use and psychotic, bipolar, depressive, and anxiety disorders, as well as suicide. It summarizes epidemiological evidence from cross-sectional and long-term prospective studies and considers possible etiological mechanisms. Methods: Systematic reviews and methodologically robust studies in the field (from inception to February 2019)

    更新日期:2020-04-23
  • Modeling the Comorbidity of Cannabis Abuse and Conduct Disorder/Conduct Problems from a Cognitive Neuroscience Perspective.
    J. Dual Diagn. (IF 1.338) Pub Date : 2019-10-14
    R James Blair

    Objective: A cognitive neuroscience perspective seeks to understand behavior, in this case the comorbidity of cannabis abuse and conduct disorder/conduct problems, in terms of dysfunction in cognitive processes underpinned by neural processes. The goal of this review is to articulate a cognitive neuroscience account of this comorbidity. Methods: Literature on the following issues will be reviewed: